25% off sitewideFree shipping over $300
Progression LabsProgression Labs

HPLC and mass spectrometry: what each assay actually proves

The two assays on almost every peptide certificate answer different questions. Reading either one as a general statement of quality is how a material with a clean certificate ends up producing an inexplicable result.

Updated · 7 min read

Reversed-phase HPLC: separation, then integration

In reversed-phase chromatography the stationary phase is non-polar — typically an octadecyl (C18) bonded silica — and the mobile phase is a water/acetonitrile gradient with an acidic modifier. Analytes partition between the two, and more hydrophobic species are retained longer. The result is a chromatogram in which components elute at characteristic times.

Purity is then an integration: the area under the main peak as a fraction of total integrated area. The method's job is to spread the peaks far enough apart that this fraction means something. A shallow gradient over a long run resolves closely-related impurities; a steep gradient over five minutes can compress a family of deletion sequences into one broad peak and report it as a single pure component.

This is why the method matters as much as the number. Two laboratories can analyse the same material and report 97% and 99.5% purity without either being dishonest, because they resolved different numbers of impurities. A certificate that states the column, gradient and detection wavelength lets you judge how hard the method was trying.

What HPLC cannot see

UV detection at 214 nm responds to the amide bond, which makes it near-universal for peptides but blind to anything without one. Inorganic salts, water and most residual solvents produce no signal and therefore do not appear in the denominator of the purity calculation.

Co-elution is the subtler limitation. An impurity that happens to share the retention time of the main compound is integrated into the main peak and inflates the purity figure. Closely related species — a single conservative substitution, a diastereomer, a deamidated variant — are exactly the impurities most likely to co-elute, and also the ones most likely to be present.

The practical consequence: a high HPLC purity is necessary but not sufficient. It constrains how much unrelated material is present. It does not, on its own, establish identity.

Mass spectrometry: identity, and a check on the chromatography

Mass spectrometry ionises the analyte and measures mass-to-charge ratio. For peptides this is usually electrospray ionisation, which is gentle enough to move an intact molecule into the gas phase, typically as a series of multiply-protonated ions.

The primary use on a certificate is confirmatory: does the measured molecular weight match the theoretical weight of the stated sequence? A match makes deletion and truncation sequences unlikely, because removing a residue changes the mass by that residue's contribution — a difference far larger than instrument error.

The secondary use is diagnostic, and it is where mass spectrometry compensates for the blind spot in chromatography. A co-eluting impurity that HPLC folded into the main peak often shows up in the mass spectrum as a distinct species. Characteristic offsets are informative: about +16 Da for oxidation, about +1 Da for deamidation, +42 Da for acetylation, and residue-sized gaps for deletions.

Why LC-MS is stronger than either alone

Running the two in series — chromatographic separation feeding directly into the mass spectrometer — gives a mass spectrum for each peak rather than one averaged spectrum for the whole sample. That is a meaningfully different measurement.

With standalone MS on bulk material, a small impurity can be lost in the noise around a dominant main-component signal. With LC-MS, that impurity is separated first and then measured on its own, so it is identified rather than merely detected. It also becomes possible to say which peak in the chromatogram corresponds to which species, instead of inferring it from retention order.

For anything where the impurity profile matters rather than just the headline percentage, LC-MS is the assay to look for on a certificate.

Reading the pair together

Treat the two results as a conjunction, not an average. High purity with a mass that does not match the sequence means a clean preparation of something other than what was ordered. A correct mass with low purity means the right compound accompanied by a substantial quantity of related material. Only both together support the claim on the label.

And neither speaks to mass fraction. Water and counter-ion content sit outside both assays, which is why a certificate can be entirely accurate and still leave the most practical question — how much compound is in this vial — unanswered.

Common questions

Why is 214 nm used instead of 280 nm?
214 nm detects the peptide backbone amide bond, so every peptide responds. 280 nm relies on aromatic side chains, so a peptide without tryptophan, tyrosine or phenylalanine would be nearly invisible.
Can HPLC purity be misleadingly high?
Yes, in two ways: a fast gradient that fails to resolve related impurities, and co-elution of a species sharing the main compound's retention time. Both inflate the integrated main-peak area.
Is LC-MS meaningfully better than separate HPLC and MS runs?
For impurity characterisation, yes. LC-MS produces a mass spectrum per chromatographic peak, so minor components are measured individually instead of being buried under the main-component signal.

Related notes

← All research notes